Want to join the conversation?
$VIAV's 4Q16 revenue was up 2% versus 4Q15, driven by growth in the OSP segment that offset decline in NSE. Operating income grew 78.7% YoverY, and operating margin of 13.5% was up 580 BPs, due to strong OSP and good OpEx management in NSE. Company OpEx fell 7.6% YoverY, driven by G&A expense reduction and R&D spend optimization.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?